Advisor Group’s Bristol-Myers Squibb BMY Stock Holding History

Advisor Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1K	Buy	+10	New	+$573	﹤0.01%	5103

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Advisor Group's BMY Position: Q4 2019 in Review

Advisor Group increased its Bristol-Myers Squibb (BMY) stake by 18% in Q4 2019, buying an estimated $2.18M and bringing the position to 253,647 shares worth $16.3M. The position accounts for 0.11% of the portfolio, ranked #164.

Advisor Group first reported a position in BMY in Q2 2016 and has held it in 15 quarters since. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

Advisor Group held 253,647 shares of Bristol-Myers Squibb worth $16.3M as of Q4 2019.
Advisor Group bought 38,046 Bristol-Myers Squibb shares in Q4 2019, an estimated $2.18M.
Bristol-Myers Squibb made up 0.11% of Advisor Group's portfolio in Q4 2019, its #164 holding.
Advisor Group first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 15 quarters since.
2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.